Janux Therapeutics Inc (JANX)

Operating Cash Flow

-$41.25M

TTM · Period ending: · USD

JANX logo

JANX Operating Cash Flow

Latest reported-$41.25M
JANX TTM Operating Cash Flow (-$4.37M → -$41.25M)
High-resolution chart · PNG

JANX operating cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Janux Therapeutics Inc Operating Cash Flow — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (USD)
-41,251,000
-77,548,000
-82,235,000
-70,418,000
-59,793,000
-46,001,000
-43,814,000
-36,990,000
-46,468,000
-51,501,000
-50,575,000
-52,587,000
-54,292,000
-45,311,000
-42,922,000
-41,490,000
-33,930,000
-34,061,000
-16,976,000
-8,124,000
-3,353,000
2,070,000
-4,369,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.